×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| Mercury Laboratories Limited | 208.44 | 11.10 | 206.59 | 9.25 | 105.0 | 34.0 |
| Achyut Healthcare Limited | NA | NA | NA | NA | 104 | 188.0 |
| IND-SWIFT LTD. | 1535.54 | 2565.99 | 1449.04 | 47.37 | 94.5 | 1.47 |
Mercury Laboratories Limited, with Security Code 538964, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16.2 | 19.4 | 18.3 | 22.8 | 17.1 | 17.4 | 16.7 | 18.2 | 19.6 | 20.7 |
| Expenses | 15.7 | 18.4 | 16.7 | 20.3 | 14.9 | 14.7 | 15.1 | 16.9 | 17.6 | 18.4 |
| Operating Profit | 0.6 | 1.0 | 1.7 | 2.5 | 2.2 | 2.7 | 1.6 | 1.3 | 2.0 | 2.2 |
| OPM % | 3.55% | 5.36% | 9.07% | 10.93% | 13.03% | 15.26% | 9.63% | 7.21% | 10.1% | 10.75% |
| Other Income | 0.6 | 0.5 | 0.1 | 0.4 | 0.2 | 0.4 | 0.2 | 0.2 | 0.5 | 0.2 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| Depreciation | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
| Profit before tax | 0.5 | 0.8 | 1.1 | 2.0 | 1.6 | 2.2 | 0.9 | 0.7 | 1.6 | 1.5 |
| Tax % | 34.4% | -54.3% | -5.3% | -25.7% | -22.1% | -15.1% | -62.9% | -23.3% | -27.4% | -20.7% |
| Net Profit | 0.6 | 0.4 | 1.0 | 1.5 | 1.2 | 1.9 | 0.3 | 0.5 | 1.2 | 1.1 |
| EPS in Rs | 5.05 | 3.05 | 8.33 | 12.56 | 10.3 | 15.92 | 2.85 | 4.17 | 9.94 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 9% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | -3% |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 12% |
| 3 Years: | 21% |
| 1 Year: | -2% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|